Why Veradermics, Incorporated’s (MANE) Stock Is Down 14.20%
As of Thursday, November 12, Veradermics, Incorporated’s MANE share price has dipped by 14.20%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Rosalio Madrigal
Rosalio Madrigal
Rosalio Madrigal
Michael Rose
| Share Statistics | MANE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5,301.4 | $436.9 | 69% |
|
| Shares Out (Mil) | 42.1 | 46.5 | 43% |
|
| Institutional Ownership | 96.7% | 82.2% | 70% |
|
| Float (Mil) | 33.2 | 47.7 | 38% |
|
| Beta | na | 0.68 | na |
|
| Avg Daily Volume (000s) | 779 | 339 | 64% |
|
| Price Change (52-week) |
na | 52.1% | na |
|
| Growth | MANE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.6% | na |
|
| Net Income (5yr) | na | (1.6%) | na |
|
| EPS (5yr) | na | 15.1% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 5 | 6 | |
| Current EPS | ($0.651) | ($2.839) | ($2.581) | |
| Month Ago EPS | ($0.616) | ($2.887) | ($2.694) | |
| # Rev Up | 2 | 2 | 2 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.609) | ($2.939) | ($2.687) | |
| Year/Year Chg | 30.5% | (97.5%) | (98.7%) | |
| Financials | MANE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $289 | na |
|
| Net Income (TTM) (Mil) | ($94) | ($11) | 11% |
|
| EPS (TTM) | ($3.868) | ($0.600) | 9% |
|
| Operating Cash Flow (TTM) (Mil) | ($82) | ($7) | 7% |
|
| Net Cash Flow (TTM) (Mil) | $127 | $1 | 80% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $6 | 14% |
|
| Enterprise Value (Q1) (Mil) | $4,911 | $331 | 63% |
|
| Valuation | MANE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.65 | 2.15 | 87% |
|
| P/E | na | 24.2 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | MANE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.5% | na |
|
| Net Margin | na | 3.6% | na |
|
| ROA | (22.7%) | (23.3%) | 19% |
|
| ROE | (26.8%) | (24.7%) | 21% |
|
| Liabilities to Assets | 1.3% | 31.8% | 0% |
|
| F-Score | 2 | 3 | 7% |
|
Veradermics, Incorporated did not pass any screens on 11/17/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors